功能性补救改善了双极性障碍的euthymic患者的血清BDNF和TrkB水平:一个随机试验研究
Ru Li1, Jiaxin Li1, Shiyi Suzy Ji2
1Unit of Bipolar Disorder, Tianjin Anding Hospital, Tianjin, People's Republic of China.
Neuropsychiatric disease and treatment
|January 30, 2025
概括
功能性补救 (FR) 增加了血清脑衍生神经营养因子 (BDNF) 和氨酸激酶受体B (TrkB) 水平在euthymic双极性障碍 (BD) 患者中. 这些变化可能解释了FR如何改善BD的症状和认知.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 生物化学 生物化学
背景情况:
- 双极性障碍 (BD) 是一种情绪障碍,其特点是交替出现躁狂和抑郁症.
- 在BD患者的euthymic阶段,在认知和情感症状管理方面存在挑战.
- 大脑衍生神经营养因子 (BDNF) 和它的受体TrkB在神经元的可塑性和功能中起着至关重要的作用,在BD中经常发生改变.
研究的目的:
- 为了研究功能补救 (FR) 对血清BDNF和TrkB水平在euthymicBD患者的影响.
- 通过其对BDNF和TrkB的影响,探索FR干预的潜在生物机制.
- 评估BDNF/TrkB水平变化与认知/情感症状变化之间的关系.
主要方法:
- 一项为期12周的随机对照试验,将FR (n=39) 与通常治疗 (TAU,n=42) 进行比较.
- 在基线和12周评估情绪症状 (HDRS-17,YMRS) 和认知功能 (MCCB).
- 在基线和12周通过血液样本分析测量血清BDNF和TrkB水平.
主要成果:
- 在FR和TAU组中,在12周内,情绪症状减少,血清BDNF/TrkB水平增加.
- 与TAU组相比,FR组的血清BDNF和TrkB水平显著增加.
- 在FR组中,BDNF水平的变化与认知变化相关 (马兹测试),改善的TrkB水平与情绪智力相关 (MSCEIT).
结论:
- 血清BDNF和TrkB水平的变化可能与FR的治疗机制有关.
- 在BD中,FR可能会增强与神经元健康和认知功能相关的神经生物学标志物.
- 需要进行更多的随访和健康对照的进一步研究来证实这些发现.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.4K
10:53Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
Published on: September 15, 2014
15.1K
相关概念视频
Bipolar Disorder
47
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
47
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Mania and Antimanic Drugs: Overview
119
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
119
REM Sleep Behavior Disorder
132
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
132
